Fund Details
Overview
Investment portfolio
15rounds
| NAME | DATE | SIZE | |
|---|---|---|---|
Encoded Therapeutics | Sep 2026Participated | $275 MSeries F | |
Proxima | Jan 2026Participated | $80 MSeed | |
Alamar Biosciences | Jan 2026Participated | $50 MOther Equity | |
Impulse Dynamics | Dec 2025Participated | $158 MOther Equity | |
Lila Sciences | Oct 2025Led | $115 MSeries A | |
Lila Sciences | Sep 2025Led | $235 MSeries A | |
Caris Life Sciences | Apr 2025Led | $168 MOther Equity | |
Perceive Pharma | Feb 2025Led | $15 MSeries A | |
Perceive Biotherapeutics | Feb 2025Participated | $15 MSeries A | |
Jade Biosciences | Oct 2024Participated | $95 MOther Equity | |
Jade Biosciences | Aug 2024Participated | $80 MOther Equity | |
LEXEO Therapeutics | Mar 2024Led | $95 MOther Equity | |
Encoded Therapeutics | Sep 2026Participated | $275 MSeries F | |
Proxima | Jan 2026Participated | $80 MSeed | |
Alamar Biosciences | Jan 2026Participated | $50 MOther Equity | |
Impulse Dynamics | Dec 2025Participated | $158 MOther Equity | |
Lila Sciences | Oct 2025Led | $115 MSeries A | |
Lila Sciences | Sep 2025Led | $235 MSeries A | |
Caris Life Sciences | Apr 2025Led | $168 MOther Equity | |
Perceive Pharma | Feb 2025Led | $15 MSeries A | |
Perceive Biotherapeutics | Feb 2025Participated | $15 MSeries A | |
Jade Biosciences | Oct 2024Participated | $95 MOther Equity | |
Jade Biosciences | Aug 2024Participated | $80 MOther Equity | |
LEXEO Therapeutics | Mar 2024Led | $95 MOther Equity |
15 Items
15
Items
...
Insights
Time horizon
View by
Deal Distribution
| Round type | Led deals | Participated deals |
|---|---|---|
| Seed | 0 | 1 |
| Series A | 3 | 1 |
| Series B | 0 | 1 |
| Series C+ | 1 | 1 |
| Other Equity | 2 | 4 |
| Debt | 1 | 0 |
Monthly Deal Activity
| Month | Deals |
|---|---|
| Jan '23 | 2 |
| Feb '23 | 0 |
| Mar '23 | 0 |
| Apr '23 | 0 |
| May '23 | 0 |
| Jun '23 | 0 |
| Jul '23 | 0 |
| Aug '23 | 0 |
| Sep '23 | 0 |
| Oct '23 | 0 |
| Nov '23 | 0 |
| Dec '23 | 1 |
| Jan '24 | 0 |
| Feb '24 | 0 |
| Mar '24 | 1 |
| Apr '24 | 0 |
| May '24 | 0 |
| Jun '24 | 0 |
| Jul '24 | 0 |
| Aug '24 | 1 |
| Sep '24 | 0 |
| Oct '24 | 1 |
| Nov '24 | 0 |
| Dec '24 | 0 |
| Jan '25 | 0 |
| Feb '25 | 2 |
| Mar '25 | 0 |
| Apr '25 | 1 |
| May '25 | 0 |
| Jun '25 | 0 |
| Jul '25 | 0 |
| Aug '25 | 0 |
| Sep '25 | 1 |
| Oct '25 | 1 |
| Nov '25 | 0 |
| Dec '25 | 1 |
| Jan '26 | 2 |
| Feb '26 | 0 |
| Mar '26 | 0 |
| Apr '26 | 0 |
| May '26 | 0 |
| Jun '26 | 0 |
| Jul '26 | 0 |
| Aug '26 | 0 |
| Sep '26 | 1 |
| Oct '26 | 0 |
Sector Breakdown
A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.
| Sector | Deals |
|---|---|
| Health & Life Sciences | 15 |
| AI & Machine Learning | 5 |
| Space & Frontier Tech | 2 |
Deal Size Distribution
Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.
| Round size band (USD) | Deals |
|---|---|
| <$5M | 0 |
| $5M-$10M | 0 |
| $10M-$25M | 2 |
| $25M-$50M | 0 |
| $50M-$100M | 6 |
| $100M-$250M | 5 |
| $250M-$500M | 2 |
| $500M-$1B | 0 |
| $1B+ | 0 |
Deals By Geography
Top 1 of 1 regions; European countries are grouped as Europe.
| Region | Deals |
|---|---|
| United States | 15 |
Co-Investors
Bubble size = shared deals
Click a bubble to open that fund in a new tab.
Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.
| Co-investor | Shared deals |
|---|---|
| Catalio Capital Management | 4 |
| Deerfield Management | 4 |
| Fairmount | 3 |
| Google Ventures | 3 |
| Johnson & Johnson Innovation | 3 |
| RD Fund | 3 |
| RTW Investments | 3 |
| Venrock | 3 |
| Collective Global | 2 |
| Deep Track Capital | 2 |
| Driehaus Capital Management | 2 |
| Flagship Pioneering | 2 |
| Franklin Templeton | 2 |
| Illumina Ventures | 2 |
| Modi Ventures | 2 |
| NVentures | 2 |
| Sands Capital | 2 |
| Abu Dhabi Investment Authority | 1 |
| Adage Capital Management | 1 |
| Aisling Capital | 1 |
Investment Strategy
| Category | Deals (count) | Share (%) |
|---|---|---|
| Led | 7 | 47% |
| Participating | 8 | 53% |
| Category | Deals (count) | Share (%) |
|---|---|---|
| Single-lead | 1 | 14% |
| Co-led | 6 | 86% |
Team
Ilan Sender
Partner
Narendra Nayak
Partner